Aragen Bioscience, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish life sciences service provider, announced the successful validation of latter’s Single-Use Production Reactors (SUPR) for large-scale recombinant antibody production. This collaboration combines Aragen’s biopharmaceutical manufacturing expertise and Getinge’s single-use technology, that aims to enable seamless production of large-scale batches.    ...